News

As of tomorrow, individual genetic risk tests are officially exempt from requiring 510(k) premarket approval, provided the company offering the test has gone through a one-time premarket review of its testing apparatus and at least one test.

Billerica, Massachusetts-based Insulet Corporation, maker of the OmniPod Insulin pump, has just announced that it received the FDA clearance to commercialize its latest product the Omnipod Dash Insulin Management System.

Consumer-grade wearables may not have the same precision as their medical-grade counterparts, but they certainly seem to by favored by patients.

Correction: A previous version of this arcticle misstated the location of company.

Telemedicine continues to move from the peripheries of healthcare into the mainstream.

The hospital joins the growing trend of fostering startups with the aim of commercializing new technologies.

Stamp of approval.

Oshi Health, a digital startup focused on digestive health, has launched a mobile app specifically designed to help inflammatory bowel disease patients understand and manage their condition.

Riverside Medical Clinic is the largest physician-owned practice in California.

Researchers at the University of Pennsylvania School of Medicine have found that telemedicine services could lead to an increase in genetic counseling in community care centers, according to an abstract that will be presented tomorrow at the American Society of Clinical Oncology's annual meeting.